The Estrogen Receptor α Signaling Pathway Controls Alternative Splicing in the Absence of Ligands in Breast Cancer Cells.
View / Open Files
Publication Date
2021-12-13Journal Title
Cancers (Basel)
ISSN
2072-6694
Publisher
MDPI AG
Volume
13
Issue
24
Language
eng
Type
Article
This Version
VoR
Metadata
Show full item recordCitation
Elhasnaoui, J., Ferrero, G., Miano, V., Cutrupi, S., & De Bortoli, M. (2021). The Estrogen Receptor α Signaling Pathway Controls Alternative Splicing in the Absence of Ligands in Breast Cancer Cells.. Cancers (Basel), 13 (24) https://doi.org/10.3390/cancers13246261
Abstract
BACKGROUND: The transcriptional activity of estrogen receptor α (ERα) in breast cancer (BC) is extensively characterized. Our group has previously shown that ERα controls the expression of a number of genes in its unliganded form (apoERα), among which a large group of RNA-binding proteins (RBPs) encode genes, suggesting its role in the control of co- and post-transcriptional events. METHODS: apoERα-mediated RNA processing events were characterized by the analysis of transcript usage and alternative splicing changes in an RNA-sequencing dataset from MCF-7 cells after siRNA-induced ERα downregulation. RESULTS: ApoERα depletion induced an expression change of 681 RBPs, including 84 splicing factors involved in translation, ribonucleoprotein complex assembly, and 3'end processing. ApoERα depletion results in 758 isoform switching events with effects on 3'end length and the splicing of alternative cassette exons. The functional enrichment of these events shows that post-transcriptional regulation is part of the mechanisms by which apoERα controls epithelial-to-mesenchymal transition and BC cell proliferation. In primary BCs, the inclusion levels of the experimentally identified alternatively spliced exons are associated with overall and disease-free survival. CONCLUSION: Our data supports the role of apoERα in maintaining the luminal phenotype of BC cells by extensively regulating gene expression at the alternative splicing level.
Keywords
Estrogen receptor, Breast cancer, Alternative splicing, Emt, Splicing Signature
Sponsorship
Italian Association for Cancer Research (15600)
Fondazione CRT (2017.0823)
University of Turin (2018 Local Research)
Identifiers
34944881, PMC8699117
External DOI: https://doi.org/10.3390/cancers13246261
This record's URL: https://www.repository.cam.ac.uk/handle/1810/333305
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk